Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI).

Stem Cell Res Ther · 2023 · PMC10324209 · PMID 37408043

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Pain scores showed a decreasing trend after treatment with P-MSCs in both dose groups, up to a decrease of 4.5 units.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.